BALA CYNWYD, Pa., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith, LLC announces that it is investigating the legal ramifications of the proposed acquisition of Advanced Medical Optics, Inc. ("Advanced Medical" or the "Company") (NYSE:EYE) by Abbott Laboratories (NYSE:ABT). Abbott Laboratories has offered Advanced Medical shareholders $22.00 a share for their stock. The deal is valued at approximately $2.8 billion in cash and debt. The deal may be undervalued as Advanced Medical stock traded at or above the offered share price through much of 2008 and as recently as September 2008, the stock was trading above the share price offered by Abbott Laboratories.
If you are an Advanced Medical shareholder and wish to discuss the legal ramifications of the proposed acquisition by Abbott Laboratories, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free 877-LEGAL-90.